Oncology & Cancer

Mass prostate cancer screening doesn't reduce deaths: study

There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington ...

Oncology & Cancer

Opting to track, not treat, early prostate cancer

(AP) -- John Shoemaker visited six doctors in his quest to find the best treatment for his early stage prostate cancer - and only the last one offered what made the most sense to the California man: Keep a close watch on ...

Health

Biopsy referral after PSA screening stays consistent over time

After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation. The US Preventive Screening Task ...

Oncology & Cancer

Age a big factor in prostate cancer deaths

Contrary to common belief, men age 75 and older are diagnosed with late-stage and more aggressive prostate cancer and thus die from the disease more often than younger men, according to a University of Rochester analysis ...

page 26 from 33